CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 124 filers reported holding CARA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,215 | -38.4% | 23,342 | +3.7% | 0.00% | – |
| Q2 2023 | $63,709 | -47.0% | 22,512 | -8.0% | 0.00% | -100.0% |
| Q1 2023 | $120,177 | -54.1% | 24,476 | +0.4% | 0.00% | -50.0% |
| Q4 2022 | $261,734 | +13.8% | 24,370 | -0.8% | 0.00% | 0.0% |
| Q3 2022 | $230,000 | +4.5% | 24,562 | +2.0% | 0.00% | +100.0% |
| Q2 2022 | $220,000 | -28.3% | 24,088 | -4.6% | 0.00% | -50.0% |
| Q1 2022 | $307,000 | -6.1% | 25,256 | -5.9% | 0.00% | 0.0% |
| Q4 2021 | $327,000 | -23.6% | 26,845 | -3.1% | 0.00% | 0.0% |
| Q3 2021 | $428,000 | +4.4% | 27,692 | -3.6% | 0.00% | +100.0% |
| Q2 2021 | $410,000 | -21.3% | 28,726 | +19.7% | 0.00% | -50.0% |
| Q1 2021 | $521,000 | +43.9% | 23,991 | +0.3% | 0.00% | +100.0% |
| Q4 2020 | $362,000 | +15.7% | 23,928 | -2.8% | 0.00% | -50.0% |
| Q3 2020 | $313,000 | -27.2% | 24,614 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $430,000 | +38.3% | 25,175 | +6.8% | 0.00% | 0.0% |
| Q1 2020 | $311,000 | -22.6% | 23,572 | -5.5% | 0.00% | 0.0% |
| Q4 2019 | $402,000 | -12.6% | 24,934 | -0.8% | 0.00% | 0.0% |
| Q3 2019 | $460,000 | -1.3% | 25,145 | +16.0% | 0.00% | 0.0% |
| Q2 2019 | $466,000 | +14.2% | 21,682 | +4.4% | 0.00% | 0.0% |
| Q1 2019 | $408,000 | +46.2% | 20,774 | -3.1% | 0.00% | +100.0% |
| Q4 2018 | $279,000 | -46.1% | 21,446 | -0.8% | 0.00% | -50.0% |
| Q3 2018 | $518,000 | +53.3% | 21,610 | +22.4% | 0.00% | +100.0% |
| Q2 2018 | $338,000 | +60.2% | 17,661 | +3.4% | 0.00% | 0.0% |
| Q1 2018 | $211,000 | -4.1% | 17,081 | -5.1% | 0.00% | 0.0% |
| Q4 2017 | $220,000 | -10.2% | 17,999 | +0.5% | 0.00% | 0.0% |
| Q3 2017 | $245,000 | -3.9% | 17,914 | +8.1% | 0.00% | 0.0% |
| Q2 2017 | $255,000 | +7.1% | 16,574 | +28.1% | 0.00% | 0.0% |
| Q1 2017 | $238,000 | +112.5% | 12,937 | +7.1% | 0.00% | – |
| Q4 2016 | $112,000 | -99.9% | 12,080 | -0.3% | 0.00% | – |
| Q3 2016 | $101,135,000 | +73.9% | 12,112 | +0.1% | 0.00% | – |
| Q2 2016 | $58,172,000 | -19.2% | 12,094 | +4.7% | 0.00% | – |
| Q1 2016 | $72,000,000 | -64.5% | 11,548 | -4.0% | 0.00% | -100.0% |
| Q4 2015 | $203,000,000 | +117923.3% | 12,023 | -0.1% | 0.00% | 0.0% |
| Q3 2015 | $172,000 | -99.9% | 12,040 | +0.1% | 0.00% | 0.0% |
| Q2 2015 | $146,153,000 | +158.2% | 12,029 | +113.5% | 0.00% | – |
| Q1 2015 | $56,611,000 | +1.6% | 5,633 | +0.8% | 0.00% | – |
| Q4 2014 | $55,712,000 | +16.0% | 5,588 | -2.3% | 0.00% | – |
| Q3 2014 | $48,008,000 | -50.7% | 5,722 | -0.1% | 0.00% | – |
| Q2 2014 | $97,440,000 | +138.0% | 5,725 | +160.2% | 0.00% | – |
| Q1 2014 | $40,942,000 | – | 2,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,204,449 | $10,824 | 1.35% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,233,000 | $6,054,030 | 1.14% |
| Chescapmanager LLC | 1,160,392 | $5,698 | 0.90% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,732,375 | $8,505,961 | 0.22% |
| XTX Topco Ltd | 107,610 | $528,365 | 0.11% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 84,530 | $415,042 | 0.08% |
| PINNACLE ASSOCIATES LTD | 679,413 | $3,335,918 | 0.07% |
| PDT Partners, LLC | 102,010 | $500,869 | 0.07% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,370 | $9,797,267 | 0.05% |
| AXQ CAPITAL, LP | 27,760 | $136,302 | 0.05% |